Skip to content
Likelier

Action vs. inaction: figure for each choice

Pursue gender-affirming care vs. living without medical treatment

If you act

Pursue gender-affirming care (hormones and/or surgery)

3.0%

If you don't

Live without gender-affirming medical treatment

No direct measurement

At least one figure is an indirect estimate, not a measured regret rate. How each figure was built is shown below.


Health

Last reviewed 2026-05-04

Evidence quality 4.5/5

Eight-dimension review score against the quality rubric . Each dimension scored 1–5.

D1 Source verification
4/5
D2 Source authority & independence
5/5
D3 Regret-rate accuracy
3/5
D4 Source comparability
4/5
D5 Gilovich pattern
5/5
D6 Prose quality
5/5
D7 Caveat completeness
5/5
D8 Sample quality
5/5
Average 4.5/5
A flat vector illustration of a simple mirror reflecting a clear calm image, muted tones
Indirect data: for this decision at least one figure comes from an indirect measure, such as outcomes, satisfaction or intent, or from an editorial estimate, rather than from a direct regret survey. The notes for each side below say how its figure was built.

If you act

Pursue gender-affirming care (hormones and/or surgery)

3.0%

~2–4% of gender-affirming surgery recipients report regret; regret rates for hormones alone are lower

Transgender and non-binary adults who received gender-affirming medical care (Bustos et al. 2021 systematic review and meta-analysis; WPATH SOC v8 review of evidence)

post-treatment follow-up (variable, 1–30 years)

If you don't

Live without gender-affirming medical treatment

No direct measurement

No source states a figure for this side, so none is shown.

Transgender and gender diverse adults without access to or who delayed gender-affirming care (2022 U.S. Transgender Survey; Turban et al. 2020, Pediatrics)

cross-sectional and retrospective; adulthood

Figure for each choice (the measure is named on the page)

Related decisions

Semantically similar decisions — same territory, different trade-offs.

Health

Korea: appearance surgery vs. declining

Figure for each choice (the measure is named on the page)

Health

Breast augmentation

Figure for each choice (the measure is named on the page)

Health

Pursue longevity vs accept aging

Figure for each choice (the measure is named on the page)

Health

Seeking therapy

Figure for each choice (the measure is named on the page)

Health

DNA ancestry/health test vs. opt out

Figure for each choice (the measure is named on the page)

Health

Cosmetic surgery

Figure for each choice (the measure is named on the page)

Health

Alt-only vs. conventional cancer

Figure for each choice (the measure is named on the page)

Health

Fertility treatment vs. childlessness

Figure for each choice (the measure is named on the page)

No survey directly measures the regret of adults who want gender-affirming care and live without it, so this side has no direct measurement, which is why this entry is flagged as proxy-only. The evidence is indirect. Turban et al.’s 2020 Pediatrics study of 20,619 transgender adults looked at those who had ever wanted pubertal suppression. The people who received it had markedly lower odds of lifetime suicidal ideation (adjusted OR 0.3) than those who wanted it but could not access it. The 2022 U.S. Transgender Survey is the largest survey of transgender people in US history, with 92,329 respondents. Nearly all care recipients said the care made them more satisfied with their lives: 98% of those receiving gender-affirming hormone therapy and 97% of those receiving transition-related surgery.

Bustos et al.’s 2021 systematic review and meta-analysis pooled 27 studies covering 7,928 patients who underwent gender-affirming surgery. The pooled regret prevalence was 1% (95% CI <1%–2%). That is consistent with the 1–4% range seen in contemporary cohorts, as patient selection and surgical techniques have improved. Regret after hormonal treatment alone is lower than after surgery. The action-side rate of 3% is a conservative estimate, since it uses the upper end of the contemporary surgical range rather than the 1% mean across all studies.

The clinical evidence on outcomes is now extensive and consistent. WPATH Standards of Care Version 8 (2022) is the most comprehensive systematic review of it. It confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety and suicidality in transgender and gender diverse adults. Set against the high satisfaction among care recipients, the surgical-regret rate is very low.

The entry concerns one population: adults with gender dysphoria who want treatment and are weighing whether to pursue it. For them the evidence consistently shows rare regret after care. People uncertain about their gender identity are outside this decision frame. Their question is different, and the evidence base for it is sparser. WPATH SOC v8 addresses the difference by recommending thorough psychological assessment before surgical interventions, though not necessarily before hormonal ones. That is the clinical standard under which the 1–4% regret rates in published studies were achieved. The regret data reflect outcomes under that assessment standard, not outcomes under zero clinical gatekeeping.

Sources: action

Claim ledger

Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.

1/2 sources independently verified verbatim against the cited source

  1. [1] International Journal of Transgender Health / WPATH — Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
    Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
    Statistic
    Systematic evidence review confirms gender-affirming care significantly reduces gender dysphoria, depression, anxiety, and suicidality; regret rates for gender-affirming surgery in recent cohorts: 1–4%
    Excerpt
    “"The WPATH Standards of Care Version 8 evidence review confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety, and suicidality in transgender and gender diverse adults. Regret rates for gender-affirming surgery, based on studies from multiple countries and time periods, range from approximately 1 to 4 percent in contemporary cohorts, with declining regret rates over time as patient selection criteria and surgical techniques have improved. Studies consistently find that the absence of gender-affirming care is associated with substantially worse mental health outcomes than receipt of care." ”
    Source data from
    2022-09-15
    Accessed
    2026-05-04
    Calculation
    WPATH SOC v8 (Coleman et al. 2022). The comprehensive WPATH evidence review is the primary authoritative source for this entry. The 1–4% surgical regret range is used; the 3% midpoint is the action-side regret_rate. Regret rates for hormones alone are lower (estimated <2%), so the 3% is a conservative upper bound reflecting the surgical-care subgroup.
  2. [2] Plastic and Reconstructive Surgery — Global Open — Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence Verified
    Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence
    Statistic
    Systematic review and meta-analysis of 27 studies pooling 7,928 transgender patients who underwent gender-affirming surgery: pooled prevalence of regret 1% (95% CI <1%–2%)
    Excerpt
    “"A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%–2%)." ”
    Source data from
    2021-03-19
    Accessed
    2026-05-04
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Bustos VP, Bustos SS, Mascaro A, et al. 2021, Plastic and Reconstructive Surgery Global Open 9(3):e3477 (DOI 10.1097/GOX.0000000000003477; PMID 33968550; PMC8099405) — systematic review and meta-analysis of 27 studies, 7,928 patients. The pooled regret prevalence of 1% (95% CI <1%–2%) is below the 3% action-side regret_rate; combined with the WPATH SOC v8 1–4% contemporary-surgery range, the 3% rate is used as a conservative upper bound for the surgical-care subgroup.

Sources: inaction

Claim ledger

Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.

1/2 sources independently verified verbatim against the cited source

  1. [1] Pediatrics — Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation Verified
    Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation
    Statistic
    Cross-sectional survey of 20,619 transgender adults; among the 16.9% (3,494) who ever wanted pubertal suppression, those who received it had lower odds of lifetime suicidal ideation than those who wanted but did not receive it (adjusted OR = 0.3; 95% CI 0.2–0.6)
    Excerpt
    “"Using a cross-sectional survey of 20 619 transgender adults aged 18 to 36 years ... Of the sample, 16.9% reported that they ever wanted pubertal suppression as part of their gender-related care ... those who received treatment with pubertal suppression, when compared with those who wanted pubertal suppression but did not receive it, had lower odds of lifetime suicidal ideation (adjusted odds ratio = 0.3; 95% confidence interval = 0.2–0.6). ... There is a significant inverse association between treatment with pubertal suppression during adolescence and lifetime suicidal ideation among transgender adults who ever wanted this treatment." ”
    Source data from
    2020-02-01
    Accessed
    2026-05-04
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Turban et al. 2020, Pediatrics 145(2):e20191725 (DOI 10.1542/peds.2019-1725; PMID 31974216; PMC7073269). Among the 3,494 transgender adults who ever wanted pubertal suppression, those who received it had markedly lower odds of lifetime suicidal ideation (aOR 0.3; CI 0.2–0.6) than those who wanted it but could not access it. This documents the elevated psychological burden borne by people who want but cannot obtain desired gender-affirming care, contextualising the inaction-side regret rate.
  2. [2] Advocates for Trans Equality (formerly National Center for Transgender Equality) — US Trans Survey
    US Trans Survey
    Statistic
    Largest US survey of transgender people (92,329 respondents): nearly all respondents who received gender-affirming care reported it made them more satisfied with their lives — gender-affirming hormone therapy 98%, transition-related surgeries 97%
    Excerpt
    “"Among those who accessed them, nearly all respondents said that gender-affirming hormone therapy (98%) or transition-related surgeries (97%) made them more satisfied with their lives." ”
    Source data from
    2024-02-08
    Accessed
    2026-05-04
    Calculation
    2022 U.S. Transgender Survey, findings page (Advocates for Trans Equality; 92,329 respondents, the largest survey of transgender people in US history). The survey measures satisfaction, not direct regret: 98% of those receiving gender-affirming hormone therapy and 97% of those receiving transition-related surgery said it made them more satisfied with their lives. The near-universal satisfaction among care recipients is the satisfaction proxy underlying the large action–inaction gap on this entry; the inaction-side rate is a derived proxy for the burden borne by those who want but cannot access desired care, not a direct regret-survey figure.

Caveats

This entry reflects the current state of the clinical evidence base for adults, as summarised in WPATH SOC v8 (2022) and the systematic literature. The action-side regret rate (3%) is for surgical care; regret rates for hormones alone are lower. The inaction side has no direct measurement and is a modeled proxy, not a measured regret figure: no survey directly asks transgender adults how many regret not accessing desired care. The available evidence is indirect — near-universal satisfaction among care recipients (98% for hormones, 97% for surgery in the 2022 U.S. Transgender Survey) and lower suicidal ideation among those who obtained desired pubertal suppression. The proxy applies specifically to adults who wanted treatment but had not received it — not to those uncertain about their gender identity or who have chosen not to seek care. These are meaningfully different populations, and this entry is flagged proxy-only. The evidence base is more limited for adolescents than for adults; the SOC v8 has separate recommendations for youth that include additional assessment requirements. The surgical-regret data comes predominantly from European cohorts (Netherlands, Sweden, Belgium) and the Bustos meta-analysis spanning 14 countries; populations in countries where gender-affirming care is restricted or criminalised face different decision structures. The consistent finding across dozens of studies is that regret after gender-affirming care is rare; this reflects the clinical literature and is not a policy position. The entry does not address which specific interventions are appropriate for specific individuals, which is a clinical determination requiring individualised assessment.

Raw data: /api/decisions.json

Recently viewed on this device